Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 24 Colorectal Neoplasms 19 Carcinoma, Non-Small-Cell Lung 19 Neoplasms 18 Recurrence 16 Pancreatic Neoplasms 16 Multiple Myeloma 15 Prostatic Neoplasms 13 Advanced Solid Tumors 12 Carcinoma, Hepatocellular 11 Stomach Neoplasms 10 Leukemia, Myeloid, Acute 10 Advanced Solid Tumor 10 Ovarian Neoplasms 9 Triple Negative Breast Neoplasms 8 Small Cell Lung Carcinoma 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Melanoma 6 Lymphoma, Large B-Cell, Diffuse 6 Head and Neck Neoplasms 6 Glioblastoma 6 Urinary Bladder Neoplasms 5 Solid Tumors 5 Lymphoma, B-Cell 5 Lung Neoplasms 5 Liver Neoplasms 5 Glioma 5 Uterine Cervical Neoplasms 4 Lymphoma 4

Interventions

trifluridine tipiracil drug combination 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Not yet recruiting × ESCC × Clear all

NCT07196345 2025-09-29

TAS-102 Plus Radiotherapy in Elderly ESCC

Qianfoshan Hospital

Phase 1/2 Not yet recruiting

ESCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡